Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Astec Lifesciences Limited ( (IN:ASTEC) ) just unveiled an update.
Astec LifeSciences Limited has announced the re-appointment of Mr. Nandkumar Dhekne as a Non-Executive & Independent Director for a second term of five years, starting from December 18, 2025, to December 17, 2030, pending shareholder approval. Mr. Dhekne brings extensive experience in field services, operations management, and sales, having held senior leadership roles across the Asia Pacific region, which is expected to bolster Astec’s strategic direction and governance.
More about Astec Lifesciences Limited
Average Trading Volume: 2,086
Technical Sentiment Signal: Sell
Current Market Cap: 17.93B INR
For a thorough assessment of ASTEC stock, go to TipRanks’ Stock Analysis page.